logo-loader

Pharma & Biotech

Add to MyProactive
Bendigo and Adelaide Bank -
on 17/2/25
Just the Facts: Recce Pharmaceuticals scores 93% efficacy in Phase II trial
on 17/2/25
Recce Pharmaceuticals Ltd - Recce Pharmaceuticals reports positive Phase II results for R327G in bacterial skin infections
on 17/2/25
Imugene Ltd - Imugene’s Phase 1b Azer-cel trial 57% complete response rate
on 14/2/25
Imugene Ltd - Imugene’s Azer-cel therapy achieves two more complete responses in patients with B-cell lymphoma blood cancer
on 14/2/25
CSL reports $2BN profit for H1 FY2025, but needs a stronger second half
on 12/2/25
The morning catch up: ASX wavers as trade uncertainty continues
on 12/2/25
Percheron Therapeutics Ltd - Percheron Therapeutics expects to receive partnering proposals this month after rapid progress in discussions
on 12/2/25
The Morning Catch Up: ASX set to rise as US stocks rally on earnings reporting wins
on 6/2/25
Anteris Technologies Global Corp - Market report: ASX falls 1.79% as market declines across all sectors
on 3/2/25
Just the Facts: Orthocell seeks Canadian approval for Remplir™
on 3/2/25
Arovella Therapeutics Ltd - Arovella fully funded through Phase 1 clinical trials for its lead program, ALA-101
on 3/2/25
Orthocell Ltd - Orthocell continues global expansion
on 3/2/25
Imugene Ltd - Imugene’s $20 million boost and cancer trial updates
on 3/2/25
The morning catch up: Trump’s tariffs to rout the ASX today
on 3/2/25
Highfield Resources Ltd -
on 31/1/25
Prescient Therapeutics prepares for transformative year with new CEO and key FDA clearance
on 31/1/25
Race Oncology Ltd - Race Oncology makes significant quarterly progress in Phase 1 RC220 trial
on 31/1/25
The morning catch up: ASX to rise ahead of CPI data
on 29/1/25
Imugene Ltd - Imugene secures A$20 million in convertible notes issue to CVI Investments
on 29/1/25
OSZAR »